HUE059569T2 - Aklidinium alkalmazása krónikus obstruktív tüdõbetegségben szenvedõ beteg napi fizikai tevékenységének növelésében - Google Patents

Aklidinium alkalmazása krónikus obstruktív tüdõbetegségben szenvedõ beteg napi fizikai tevékenységének növelésében

Info

Publication number
HUE059569T2
HUE059569T2 HUE13805376A HUE13805376A HUE059569T2 HU E059569 T2 HUE059569 T2 HU E059569T2 HU E13805376 A HUE13805376 A HU E13805376A HU E13805376 A HUE13805376 A HU E13805376A HU E059569 T2 HUE059569 T2 HU E059569T2
Authority
HU
Hungary
Prior art keywords
aclidinium
increasing
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
HUE13805376A
Other languages
English (en)
Hungarian (hu)
Inventor
Fernandez Diana Jarreta
Gil Maria Esther Garcia
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of HUE059569T2 publication Critical patent/HUE059569T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE13805376A 2012-12-17 2013-12-13 Aklidinium alkalmazása krónikus obstruktív tüdõbetegségben szenvedõ beteg napi fizikai tevékenységének növelésében HUE059569T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382507 2012-12-17
US201361750952P 2013-01-10 2013-01-10

Publications (1)

Publication Number Publication Date
HUE059569T2 true HUE059569T2 (hu) 2022-11-28

Family

ID=47458806

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13805376A HUE059569T2 (hu) 2012-12-17 2013-12-13 Aklidinium alkalmazása krónikus obstruktív tüdõbetegségben szenvedõ beteg napi fizikai tevékenységének növelésében

Country Status (23)

Country Link
US (3) US20150328194A1 (https=)
EP (1) EP2931275B1 (https=)
JP (1) JP6346618B2 (https=)
KR (1) KR20150096400A (https=)
CN (1) CN104869996A (https=)
AR (1) AR094063A1 (https=)
AU (1) AU2013363837A1 (https=)
CA (1) CA2892928A1 (https=)
CY (1) CY1125541T1 (https=)
DK (1) DK2931275T3 (https=)
ES (1) ES2917879T3 (https=)
HR (1) HRP20221034T1 (https=)
HU (1) HUE059569T2 (https=)
IL (1) IL239245A0 (https=)
LT (1) LT2931275T (https=)
PL (1) PL2931275T3 (https=)
PT (1) PT2931275T (https=)
RS (1) RS63476B1 (https=)
SI (1) SI2931275T1 (https=)
SM (1) SMT202200303T1 (https=)
TW (1) TW201427660A (https=)
UY (1) UY35196A (https=)
WO (1) WO2014095663A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT837710E (pt) 1995-06-21 2002-05-31 Sofotec Gmbh & Co Kg Cartucho de po farmaceutico com dispositivo de doseamento integrado e inalador para medicamentos em po
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2232306B1 (es) 2003-11-10 2006-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251867B1 (es) 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
PT1616592E (pt) 2004-07-16 2010-12-10 Almirall Sa Inalador para administração de fármacos em pó e um cartucho de pó para utilização com este inalador
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors

Also Published As

Publication number Publication date
DK2931275T3 (da) 2022-07-04
US20180000798A1 (en) 2018-01-04
IL239245A0 (en) 2015-07-30
JP2016502992A (ja) 2016-02-01
CY1125541T1 (el) 2026-02-25
AR094063A1 (es) 2015-07-08
CA2892928A1 (en) 2014-06-26
US20160331733A1 (en) 2016-11-17
ES2917879T3 (es) 2022-07-12
SI2931275T1 (sl) 2022-07-29
JP6346618B2 (ja) 2018-06-20
KR20150096400A (ko) 2015-08-24
UY35196A (es) 2014-07-31
LT2931275T (lt) 2022-06-27
HRP20221034T1 (hr) 2022-11-11
WO2014095663A1 (en) 2014-06-26
AU2013363837A1 (en) 2015-06-11
SMT202200303T1 (it) 2022-09-14
PL2931275T3 (pl) 2022-09-05
RS63476B1 (sr) 2022-08-31
US20150328194A1 (en) 2015-11-19
EP2931275A1 (en) 2015-10-21
CN104869996A (zh) 2015-08-26
TW201427660A (zh) 2014-07-16
PT2931275T (pt) 2022-06-30
EP2931275B1 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
ZA201405610B (en) Prediction of outcome in patients with chronic obstructive pulmonary disease
IL239025A0 (en) Treatment of lung disease
PL2845593T3 (pl) Pochodne pirydyny i pirazyny do leczenia przewlekłej obturacyjnej choroby płuc
EP2593001C0 (en) NON-INVASIVE MONITORING OF PHYSIOLOGICAL CONDITIONS
EP2913047A4 (en) Pulmonary disease-specific therapeutic agent
DK3730136T3 (da) Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom
PL2708260T3 (pl) Urządzenie do leczenia chorób układu oddechowego oraz poprawiania czynności płuc
HRP20181378T1 (hr) Postupci liječenja pedijatrijskih pacijenata deksmedetomidinom
ZA201409184B (en) Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders
IL237021B (en) Pharmaceutical composition for treatment of pulmonary arterial hypertension with mesenchymal stem cells
HUE053409T2 (hu) Ortopédiai szék a gerincbetegségek kezelésére és megelõzésére
EP2710926A4 (en) Simple self-assembly chair for health
AP3768A (en) Asymmetric ureas and medical uses thereof
IL225668A (en) Formulations for the treatment of disorders of the upper respiratory tract
BR112014009789A2 (pt) cisteamina no tratamento da doença fibrótica
CY2020015I2 (el) Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
EP2861244A4 (en) TREATMENT OF SLEEP APNEA
LT2704711T (lt) Fk506 panaudojimas plaučių arterinei hipertenzijai gydyti
IL227666A0 (en) Aclidinium for use in improving the quality of sleep in respiratory patients
HUE059569T2 (hu) Aklidinium alkalmazása krónikus obstruktív tüdõbetegségben szenvedõ beteg napi fizikai tevékenységének növelésében
PL2702033T3 (pl) Zastosowanie soli 3-karboksy-N-etylo-N,N-dimetylopropano-1-amoniowych do leczenia choroby układu krążenia
TH1401003444A (th) องค์ประกอบดูแลสุขภาพปาก
UA23782S (uk) Тумбочка багатоярусна «коміdin»
FI20115180L (fi) Koostumus käytettäväksi sairauden hoidossa
ES1073724Y (es) Protesis para tratamiento del pie plano